Fleury S.A. (BVMF:FLRY3)

Fleury Revenue

Fleury had revenue of 2.49B BRL in the quarter ending September 30, 2026, with 13.42% growth. This brings the company's total for the last twelve months to 9.09B, up 12.58% year-over-year. In the year 2025, Fleury had annual revenue of 8.29B with 7.89% growth. That makes Fleury the 5,658th largest company in the world by revenue and 93rd in Brazil.

• Revenue (ttm): 9.09B
• Revenue Growth: +12.58%
• P/S Ratio: 1.25
• Revenue / Employee: 313.29K
• Employees: 29,000
• Market Cap: 11.35B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Diagnostic Medicine 5.78B 69.7%
• Integrated Medicine 2.51B 30.3%

Fiscal year ended Dec 31, 2025 See the full Fleury breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	8.29B	606.52M	7.89%
Dec 31, 2024	7.68B	1.21B	18.76%
Dec 31, 2023	6.47B	2.01B	44.99%
Dec 31, 2022	4.46B	590.39M	15.25%
Dec 31, 2021	3.87B	901.04M	30.32%

Data Source: S&P Global Market Intelligence Last updated: Nov 5, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 10, 2026

Data Sources Report a data error